MilliporeSigma’s new BioContinuum Seed Train Platform offering enables a fully closed bioprocessing environment for both fed-batch and perfusion N-production. On June 27, 2022, MilliporeSigma, the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results